Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects

NCT04303039 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout
Food-drug Interaction

Interventions

DRUG: ABP-671

Sponsor

Atom Therapeutics Co., Ltd